Neuronetics appointed Nir Naor as Executive Vice President, Chief Financial Officer and Treasurer, effective on or about July 23, 2026, while W. Andrew Macan will depart as Executive Vice President, Chief Legal Officer and Corporate Secretary with a Separation Date of August 15, 2026.
| IndividualW. Andrew MacanNir Naor | RoleExecutive Vice President, Chief Legal Officer, Corporate SecretaryExecutive Vice President, Chief Financial Officer, Treasurer | Type of ChangeSeparation / DepartureAppointment | Effective DateAugust 15, 2026On or about July 23, 2026 | ReasonNot the result of any dispute or disagreement with the Company, management, or BoardNot disclosed | Replacement InfoNot disclosedN/A | Background DetailsServed in role since January 21, 2020; Separation Agreement provides retention bonus, vested RSUs and separation paymentAge 51; 20+ years finance and life sciences experience; prior CFO roles at Axogen, HMNC Brain Health, Arbor Pharmaceuticals; senior finance roles at Molnlycke, UCB, AstraZeneca; MBA (IMD), LL.M. (Hamburg), LL.B. and accounting degrees (Tel-Aviv University); CFA® charterholder | Board/Committee Role ChangesNot disclosedNot disclosed |
Original SEC Filing:
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.